Alyeska Investment Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-534,309	Closed	-$1.23M	–	607
2018 Q2	$1.23M	Buy	534,309 +17,086	+3%	+$49.8K	0.01%	385
2018 Q1	$1.65M	Sell	517,223 -4,660	-0.9%	-$12.8K	0.01%	363
2017 Q4	$2.14M	Hold	521,883	–	–	0.02%	331
2017 Q3	$2.36M	Buy	521,883 +9,320	+2%	+$37.8K	0.02%	346
2017 Q2	$1.71M	Sell	512,563 -193,677	-27%	-$804K	0.01%	362
2017 Q1	$6.5M	Buy	706,240 +16,986	+2%	+$149K	0.05%	287
2016 Q4	$5.31M	Sell	689,254 -182,048	-21%	-$1.67M	0.04%	319
2016 Q3	$9.96M	Buy	871,302 +439,572	+102%	+$5.12M	0.09%	268
2016 Q2	$5.32M	Buy	431,730 +106,730	+33%	+$1.3M	0.05%	298
2016 Q1	$3.29M	Buy	325,000 +165,802	+104%	+$1.95M	0.03%	305
2015 Q4	$3.59M	Sell	159,198 -47,285	-23%	-$969K	0.04%	274
2015 Q3	$3.43M	Buy	206,483 +18,898	+10%	+$379K	0.04%	292
2015 Q2	$4.22M	Buy	187,585 +28,034	+18%	+$691K	0.06%	286
2015 Q1	$4.11M	Sell	159,551 -93,107	-37%	-$2.36M	0.06%	303
2014 Q4	$5.5M	Sell	252,658 -50,257	-17%	-$1.03M	0.1%	261
2014 Q3	$5.73M	Buy	302,915 +52,481	+21%	+$1.05M	0.13%	215
2014 Q2	$5.83M	Sell	250,434 -11,329	-4%	-$280K	0.16%	210
2014 Q1	$8.81M	Sell	261,763 -17,817	-6%	-$600K	0.32%	151
2013 Q4	$8.25M	Buy	279,580 +10,583	+4%	+$194K	0.39%	116
2013 Q3	$4.12M	Buy	+268,997	New	+$4.98M	0.23%	171

Other funds holding OMED